Caribou Biosciences, Inc. (CRBU) Earnings History
Annual and quarterly earnings data from 2019 to 2025
Loading earnings history...
CRBU EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CRBU Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | 60.7% | -1667.2% | -1491.9% |
| 2023 | 89.8% | -336.6% | -296.1% |
| 2022 | 73.7% | -768.2% | -717.8% |
| 2021 | 89.7% | -697.8% | -697.3% |
Download Data
Export CRBU earnings history in CSV or JSON format
Free sign-in required to download data
Caribou Biosciences, Inc. (CRBU) Earnings Overview
As of May 8, 2026, Caribou Biosciences, Inc. (CRBU) reported trailing twelve-month net income of -$157M, reflecting +3.6% year-over-year growth. The company earned $-1.68 per diluted share over the past four quarters.
Looking at the long-term picture, CRBU's historical earnings data spans multiple years. The company achieved its highest annual net income of -$23M in fiscal 2019.
Caribou Biosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including EDIT (-$160M net income), BEAM (-$65M net income, -57.2% margin), NTLA (-$413M net income, -609.9% margin), CRBU has comparable earnings metrics. Compare CRBU vs EDIT →
CRBU Earnings vs Peers
Earnings metrics vs comparable public companies
CRBU Historical Earnings Data (2019–2025)
7 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$148M | +0.7% | -$148M | $-1.59 | - | - |
| 2024 | -$149M | -46.1% | -$167M | $-1.65 | -1491.9% | -1667.2% |
| 2023 | -$102M | -2.7% | -$116M | $-1.38 | -296.1% | -336.6% |
| 2022 | -$99M | -48.6% | -$106M | $-1.64 | -717.8% | -768.2% |
| 2021 | -$67M | -95.1% | -$67M | $-1.11 | -697.3% | -697.8% |
| 2020 | -$34M | -46.4% | -$36M | $-1.24 | -277.6% | -292.2% |
| 2019 | -$23M | - | -$34M | $-0.85 | -404.8% | -592.7% |
See CRBU's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CRBU Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CRBU vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCRBU — Frequently Asked Questions
Quick answers to the most common questions about buying CRBU stock.
Is CRBU growing earnings?
CRBU EPS of $-1.68 reflects slowing growth at +3.6%, below the 5-year CAGR of N/A. TTM net income is $-157M. Expansion rate has moderated.
What are CRBU's profit margins?
Caribou Biosciences, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are CRBU's earnings?
CRBU earnings data spans 2019-2025. The current earnings trend is +3.6% YoY. Historical data enables comparison across business cycles.